BioCentury
ARTICLE | Clinical News

Masitinib: Phase II ongoing

August 17, 2015 7:00 AM UTC

AB Science said an independent DSMB recommended for a second time continuation of a Phase II trial evaluating oral masitinib in combination with etoposide or irinotecan in patients who relapsed after ...